Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Dr. Christina Smolke is a Professor in the Chemical Engineering Department at Caltech. She graduated from USC with a B.S. degree in Chemical Engineering with an emphasis in Biology in 1997. She then attended the University of California at Berkeley and earned her Ph.D. in 2001 in Chemical Engineering under Professor Jay D. Keasling. Before starting her position at Caltech, Christina conducted a two year postdoctoral fellowship in the Cell Biology Department at UC Berkeley under the guidance of Professor Karsten Weis.

Christina's lab is interested in using a combination of interdisciplinary approaches encompassing biomolecular engineering, biochemical engineering, and synthetic biology with a strong foundation in molecular biology, biochemistry, and chemical biology to study complex gene regulatory networks and develop sophisticated gene expression technologies.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »